Aclarion Shares Are Trading Higher After the Company Announced That Its Nociscan Solution Will Be Used in the Upcoming LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
Aclarion宣佈將在即將進行的評估慢性腰痛診斷和治療的LIFEHAB試驗中使用其Nociscan解決方案後,該公司股價走高